Anthony L. Nicholas

Person

Oregon, WI, US

People

Patents Grantslast 30 patents

Information Patent Grant
RNAi agents for inhibiting expression of PNPLA3, pharmaceutical com...
- Patent number 12,054,718
- Issue date Aug 6, 2024
- Arrowhead Pharmaceuticals, Inc.
- Anthony Nicholas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RNAi agents for inhibiting expression of Superoxide Dismutase 1 (SO...
- Patent number 11,912,997
- Issue date Feb 27, 2024
- Arrowhead Pharmaceuticals, Inc.
- Christine Esau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RNAi agents for inhibiting expression of DUX4, compositions thereof...
- Patent number 11,845,937
- Issue date Dec 19, 2023
- Arrowhead Pharmaceuticals, Inc.
- Zhi-Ming Ding
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for inhibiting gene expression of Hif2alpha
- Patent number 11,840,688
- Issue date Dec 12, 2023
- Arrowhead Pharmaceuticals, Inc.
- So Wong
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
RNAi agents for inhibiting expression of xanthine dehydrogenase (XD...
- Patent number 11,629,349
- Issue date Apr 18, 2023
- Arrowhead Pharmaceuticals, Inc.
- Anthony Nicholas
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
RNAi agents for inhibiting expression of xanthine dehydrogenase (XD...
- Patent number 11,549,112
- Issue date Jan 10, 2023
- Arrowhead Pharmaceuticals, Inc.
- Anthony Nicholas
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
RNAi agents for inhibiting expression of alpha-ENaC and methods of use
- Patent number 11,214,802
- Issue date Jan 4, 2022
- Arrowhead Pharmaceuticals, Inc.
- Zhen Li
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Alpha-v beta-6 integrin ligands and uses thereof
- Patent number 11,180,529
- Issue date Nov 23, 2021
- Arrowhead Pharmaceuticals, Inc.
- Aaron Almeida
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for inhibiting gene expression of Hif2alpha
- Patent number 10,927,373
- Issue date Feb 23, 2021
- Arrowhead Pharmaceuticals, Inc.
- So Wong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RNAi agents for inhibiting expression of alpha-ENaC and methods of use
- Patent number 10,590,416
- Issue date Mar 17, 2020
- Arrowhead Pharmaceuticals, Inc.
- Zhen Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for inhibiting gene expression of Hif2alpha
- Patent number 9,976,141
- Issue date May 22, 2018
- Arrowhead Pharmaceuticals, Inc.
- So Wong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
RNAi Agents for Inhibiting Expression of Coronavirus (CoV) Viral Ge...
- Publication number 20240392292
- Publication date Nov 28, 2024
- Arrowhead Pharmaceuticals, Inc.
- Christine I Wooddell
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RNAi Agents for Inhibiting Expression of Superoxide Dismutase 1 (SO...
- Publication number 20240026363
- Publication date Jan 25, 2024
- Arrowhead Pharmaceuticals, Inc.
- Christine Esau
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RNAi Agents for Inhibiting Expression of DUX4, Compositions Thereof...
- Publication number 20230416737
- Publication date Dec 28, 2023
- Arrowhead Pharmaceuticals, Inc.
- Zhi-Ming Ding
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNAi Agents for Inhibiting Expression of Matrix Metalloproteinase 7...
- Publication number 20230265437
- Publication date Aug 24, 2023
- Arrowhead Pharmaceuticals, Inc.
- Anthony Nicholas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNAi Agents for Inhibiting Expression of DUX4, Compositions Thereof...
- Publication number 20230265430
- Publication date Aug 24, 2023
- Arrowhead Pharmaceuticals, Inc.
- Zhi-Ming Ding
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNAi Agents for Inhibiting Expression of Xanthine Dehydrogenase (XD...
- Publication number 20230139166
- Publication date May 4, 2023
- Arrowhead Pharmaceuticals, Inc.
- Anthony NICHOLAS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RNAi Agents for Inhibiting Expression of Xanthine Dehydrogenase (XD...
- Publication number 20230125671
- Publication date Apr 27, 2023
- Arrowhead Pharmaceuticals, Inc.
- Anthony NICHOLAS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RNAi Agents for Inhibiting Expression of Beta-ENaC, Compositions Th...
- Publication number 20230013022
- Publication date Jan 19, 2023
- Arrowhead Pharmaceuticals, Inc.
- Anthony Nicholas
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RNAi Agents for Inhibiting Expression of Xanthine Dehydrogenase (XD...
- Publication number 20230013224
- Publication date Jan 19, 2023
- Arrowhead Pharmaceuticals, Inc.
- Anthony NICHOLAS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RNAi Agents for Inhibiting Expression of Xanthine Dehydrogenase (XD...
- Publication number 20230002773
- Publication date Jan 5, 2023
- Arrowhead Pharmaceuticals, Inc.
- Anthony NICHOLAS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RNAi Agents for Inhibiting Expression of Mucin 5AC (MUC5AC), Compos...
- Publication number 20230002767
- Publication date Jan 5, 2023
- Arrowhead Pharmaceuticals, Inc.
- Erik W. Bush
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNAi Agents for Inhibiting Expression of Receptor for Advanced Glyc...
- Publication number 20220396791
- Publication date Dec 15, 2022
- Arrowhead Pharmaceuticals, Inc.
- Anthony Nicholas
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RNAi Agents for Inhibiting Expression of HIF-2 alpha (EPAS1), Compo...
- Publication number 20220204976
- Publication date Jun 30, 2022
- Arrowhead Pharmaceuticals, Inc.
- Zhen Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNAi Agents for Inhibiting Expression of Alpha-ENaC And Methods of Use
- Publication number 20220090077
- Publication date Mar 24, 2022
- Arrowhead Pharmaceuticals, Inc.
- Zhen Li
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ALPHA-V BETA-6 INTEGRIN LIGANDS AND USES THEREOF
- Publication number 20220024975
- Publication date Jan 27, 2022
- Arrowhead Pharmaceuticals, Inc.
- Aaron Almeida
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RNAi Agents For Inhibiting Expression Of PNPLA3, Pharmaceutical Com...
- Publication number 20210301294
- Publication date Sep 30, 2021
- Arrowhead Pharmaceuticals, Inc.
- Anthony Nicholas
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Compositions and Methods for Inhibiting Gene Expression of Hif2alpha
- Publication number 20210180066
- Publication date Jun 17, 2021
- Arrowhead Pharmaceuticals, Inc.
- So Wong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTEGRIN TARGETING LIGANDS AND USES THEREOF
- Publication number 20210093725
- Publication date Apr 1, 2021
- Arrowhead Pharmaceuticals, Inc.
- Zhen Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTEGRIN TARGETING LIGANDS AND USES THEREOF
- Publication number 20210069337
- Publication date Mar 11, 2021
- Arrowhead Pharmaceuticals, Inc.
- Zhen Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNAi Agents for Inhibiting Expression of Alpha-ENaC And Methods of Use
- Publication number 20200299691
- Publication date Sep 24, 2020
- Arrowhead Pharmaceuticals, Inc.
- Zhen Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALPHA-V BETA-6 INTEGRIN LIGANDS AND USES THEREOF
- Publication number 20190248832
- Publication date Aug 15, 2019
- Arrowhead Pharmaceuticals, Inc.
- Aaron Almeida
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNAi Agents for Inhibiting Expression of Alpha-ENaC And Methods of Use
- Publication number 20190010494
- Publication date Jan 10, 2019
- Arrowhead Pharmaceuticals, Inc.
- Zhen Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and Methods for Inhibiting Gene Expression of Hif2alpha
- Publication number 20180230470
- Publication date Aug 16, 2018
- Arrowhead Pharmaceuticals, Inc.
- So Wong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and Methods for Inhibiting Gene Expression of Hif2alpha
- Publication number 20160348107
- Publication date Dec 1, 2016
- ARROWHEAD MADISON INC.
- So Wong
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Anthony L. Nicholas

Person

Patents Grantslast 30 patents

RNAi agents for inhibiting expression of PNPLA3, pharmaceutical com...

RNAi agents for inhibiting expression of Superoxide Dismutase 1 (SO...

RNAi agents for inhibiting expression of DUX4, compositions thereof...

Compositions and methods for inhibiting gene expression of Hif2alpha

RNAi agents for inhibiting expression of xanthine dehydrogenase (XD...

RNAi agents for inhibiting expression of xanthine dehydrogenase (XD...

RNAi agents for inhibiting expression of alpha-ENaC and methods of use

Alpha-v beta-6 integrin ligands and uses thereof

Compositions and methods for inhibiting gene expression of Hif2alpha

RNAi agents for inhibiting expression of alpha-ENaC and methods of use

Compositions and methods for inhibiting gene expression of Hif2alpha

Patents Applicationslast 30 patents

RNAi Agents for Inhibiting Expression of Coronavirus (CoV) Viral Ge...

RNAi Agents for Inhibiting Expression of Superoxide Dismutase 1 (SO...

RNAi Agents for Inhibiting Expression of DUX4, Compositions Thereof...

RNAi Agents for Inhibiting Expression of Matrix Metalloproteinase 7...

RNAi Agents for Inhibiting Expression of DUX4, Compositions Thereof...

RNAi Agents for Inhibiting Expression of Xanthine Dehydrogenase (XD...

RNAi Agents for Inhibiting Expression of Xanthine Dehydrogenase (XD...

RNAi Agents for Inhibiting Expression of Beta-ENaC, Compositions Th...

RNAi Agents for Inhibiting Expression of Xanthine Dehydrogenase (XD...

RNAi Agents for Inhibiting Expression of Xanthine Dehydrogenase (XD...

RNAi Agents for Inhibiting Expression of Mucin 5AC (MUC5AC), Compos...

RNAi Agents for Inhibiting Expression of Receptor for Advanced Glyc...

RNAi Agents for Inhibiting Expression of HIF-2 alpha (EPAS1), Compo...

RNAi Agents for Inhibiting Expression of Alpha-ENaC And Methods of Use

ALPHA-V BETA-6 INTEGRIN LIGANDS AND USES THEREOF

RNAi Agents For Inhibiting Expression Of PNPLA3, Pharmaceutical Com...

Compositions and Methods for Inhibiting Gene Expression of Hif2alpha

INTEGRIN TARGETING LIGANDS AND USES THEREOF

INTEGRIN TARGETING LIGANDS AND USES THEREOF

RNAi Agents for Inhibiting Expression of Alpha-ENaC And Methods of Use

ALPHA-V BETA-6 INTEGRIN LIGANDS AND USES THEREOF

RNAi Agents for Inhibiting Expression of Alpha-ENaC And Methods of Use

Compositions and Methods for Inhibiting Gene Expression of Hif2alpha

Compositions and Methods for Inhibiting Gene Expression of Hif2alpha